Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter?
暂无分享,去创建一个
Anne Mills | S. P. Kachur | Catherine Goodman | A. Mills | S. Abdulla | P. Bloland | C. Goodman | Salim Abdulla | S Patrick Kachur | Peter Bloland | S. Kachur
[1] C. Goodman. An economic analysis of the retail market for fever and malaria treatment in rural Tanzania , 2005 .
[2] A. Zwi,et al. Carrot and stick: state mechanisms to influence private provider behavior. , 1994, Health policy and planning.
[3] A. Zwi,et al. Sexually transmitted disease control in developing countries: the challenge of involving the private sector. , 1999, Sexually transmitted infections.
[4] A. Mills,et al. Retail supply of malaria‐related drugs in rural Tanzania: risks and opportunities , 2004, Tropical medicine & international health : TM & IH.
[5] F. Thompson. Street-Level Bureaucracy: Dilemmas of the Individual in Public Services , 1983 .
[6] R. Mpembeni,et al. How do countries regulate the health sector? Evidence from Tanzania and Zimbabwe. , 2000, Health policy and planning.
[7] S. McCombie,et al. Self-treatment for malaria: the evidence and methodological issues. , 2002, Health policy and planning.
[8] J. Hammer. To prescribe or not to prescribe: on the regulation of pharmaceuticals in less developed countries. , 1992, Social science & medicine.
[9] G. Tomson,et al. A Household Survey of Source, Availability, and use of Antimalarials in a Rural Area of Tanzania , 1999 .
[10] B. Eriksson,et al. PRIVATE PHARMACY PRACTICE AND REGULATION , 2001, International Journal of Technology Assessment in Health Care.
[11] Michael Hill,et al. Implementing public policy , 2002 .
[12] R. Mpembeni,et al. Coping with private health markets: regulatory effectiveness in Sub-Saharan Africa , 2003 .
[13] L. Kumaranayake. Economic aspects of health sector regulation: strategic choices for low and middle income countries , 1998 .
[14] L. Kumaranayake,et al. Do they work? Regulating for-profit providers in Zimbabwe. , 2000, Health policy and planning.
[15] G. Tomson,et al. Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania , 2003, Journal of clinical pharmacy and therapeutics.
[16] R. Snow,et al. The difference between effectiveness and efficacy of antimalarial drugs in Kenya , 2004, Tropical medicine & international health : TM & IH.
[17] S. Salim,et al. Sales practices of patent medicine sellers in Nigeria , 1996 .
[18] J. Remon,et al. In vitro evaluation of the quality of essential drugs on the Tanzanian market , 2002, Tropical medicine & international health : TM & IH.
[19] John Walker. Implementation , 2001, Kant, Applied.
[20] O. Shakoor,et al. Assessment of the incidence of substandard drugs in developing countries , 1997, Tropical medicine & international health : TM & IH.
[21] P. Byass,et al. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[22] L. Kumaranayake. THE ROLE OF REGULATION: INFLUENCING PRIVATE SECTOR ACTIVITY WITHIN HEALTH SECTOR REFORM , 1997 .
[23] D. Okello,et al. Quality of oral and parenteral chloroquine in Kampala. , 1998, East African medical journal.
[24] M. Tanner,et al. Diagnostic accuracy and case management of clinical malaria in the primary health services of a rural area in south‐eastern Tanzania , 2001, Tropical medicine & international health : TM & IH.
[25] S. van der Geest,et al. Self-care and the informal sale of drugs in south Cameroon. , 1987, Social science & medicine.
[26] R. Northrup,et al. Utilizing the potential of formal and informal private practitioners in child survival: situation analysis and summary of promising interventions. , 2002 .
[27] M. Mackintosh,et al. Inclusion by Design? Rethinking Health Care Market Regulation in the Tanzanian Context , 2002 .
[28] P. Berman,et al. Organization of ambulatory care provision: a critical determinant of health system performance in developing countries. , 2000, Bulletin of the World Health Organization.
[29] S. Abdulla,et al. Human resources for health: requirements and availability in the context of scaling-up priority interventions in low-income countries. Case studies from Tanzania and Chad , 2003 .
[30] S. Abdulla,et al. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004 , 2006, Tropical medicine & international health : TM & IH.
[31] M. Petzold,et al. Effectiveness of a multi-component intervention on dispensing practices at private pharmacies in Vietnam and Thailand--a randomized controlled trial. , 2005, Social science & medicine.
[32] O. Shakoor,et al. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies , 2001, The Lancet.
[33] D. Peters,et al. Working with the private sector for child health. , 2003, Health policy and planning.
[34] Jon Pierre,et al. Handbook of public administration , 2003 .
[35] M. Tanner,et al. The incidence of clinical malaria detected by active case detection in children in Ifakara, southern Tanzania. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[36] W. Brieger,et al. Primary care training for patent medicine vendors in rural Nigeria. , 1992, Social science & medicine.
[37] S. Soumerai,et al. Retail pharmacies in developing countries: a behavior and intervention framework. , 1996, Social science & medicine.
[38] G. Bloom,et al. Pluralism and marketisation in the health sector : meeting health needs in contexts of social change in low and middle-income countries , 2001 .
[39] A. Zwi,et al. Working with private sector providers for better health care, an introductory guide. , 2001 .
[40] A. Hardon,et al. Popular pills : community drug use in Uganda , 1996 .
[41] L. Basco,et al. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. , 2004, The American journal of tropical medicine and hygiene.
[42] A. Escalante,et al. Molecular epidemiology of malaria in Cameroon. XVIII. Polymorphisms of the Plasmodium falciparum merozoite surface antigen-2 gene in isolates from symptomatic patients. , 2004, The American journal of tropical medicine and hygiene.
[43] Caroline O H Jones,et al. A critical review of behavioral issues related to malaria control in sub-Saharan Africa: what contributions have social scientists made? , 2004, Social Science & Medicine (1967).
[44] R. Tahar,et al. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children. , 2007, Acta tropica.
[45] M. Uplekar,et al. Tuberculosis patients and practitioners in private clinics in India. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[46] C. Goodman,et al. Improving the Supply Distribution and Use of Antimalarial Drugs by the Private Sector in Tanzania. Report prepared for the National Malaria Control Programme, United Republic of Tanzania , 2003 .
[47] D. Fassin. Illicit sale of pharmaceuticals in Africa: sellers and clients in the suburbs of Dakar. , 1988, Tropical and geographical medicine.